Liabilities and Equity of DA32 Life Science Tech Acquisition Corp. from 30 Sep 2021 to 31 Mar 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: DA32 Life Science Tech Acquisition Corp. quarterly Liabilities and Equity in USD history and change rate from 30 Sep 2021 to 31 Mar 2023.
DA32 Life Science Tech Acquisition Corp. Liabilities and Equity for the quarter ending 31 Mar 2023 was $204,984,219, a 1.4% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

DA32 Life Science Tech Acquisition Corp. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	$204,984,219	+$2,774,125	+1.4%	31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q4 2022	$203,855,661	+$1,362,732	+0.67%	31 Dec 2022	10-Q	12 May 2023	2023	Q1
Q3 2022	$202,405,559	-$274,833	-0.14%	30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$201,739,026			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$202,210,094			31 Mar 2022	10-Q	13 May 2022	2022	Q1
Q4 2021	$202,492,929			31 Dec 2021	10-K	29 Mar 2023	2022	FY
Q3 2021	$202,680,392			30 Sep 2021	10-Q	15 Nov 2021	2021	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.